Weight-Loss Drugs Reshape Industries, From Beer to Beauty

The burgeoning popularity of weight-loss drugs like Ozempic and Wegovy is creating ripple effects across multiple sectors, impacting everything from alcohol consumption to beauty product sales. Heineken, the world's second-largest brewer, has cautioned British pubs and bars that these GLP-1 medications can diminish the desire for alcohol, potentially leading to reduced beer and cider sales.

Similarly, beauty giant L'Oréal has acknowledged that the widespread use of these drugs is a significant phenomenon affecting its beauty and skincare sales. The drugs' ability to induce feelings of fullness and reduce cravings is altering consumer behavior in ways that are now being closely monitored by industries reliant on traditional consumption patterns.